COMPANY PROFILE · UPDATED 18 NOV 2025
Retension Pharmaceuticals
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical…
This profile is unclaimed — do you work here? Claim it
Claim it →- Founded
- 2023
- Headcount
- 2
- Open roles
- 0
- Last raised
- Series B · Sign in to view
LEADERSHIP
Founders & key people
OPEN ROLES
Roles at Retension Pharmaceuticals
Employbl doesn’t track Retension Pharmaceuticals’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →
FUNDING
Capital raised
TAGS
Categorized in
LOCATIONS
Where they work
Retension Pharmaceuticals offices
Loading map…
- Falls Church, VA1104 West Broad Street #1029
SIMILAR COMPANIES
Companies like Retension Pharmaceuticals
Similar companies
